Streetbeat News

Analyst Ratings

K

Barclays analyst Andrew Lazar has upgraded Kellanova (NYSE:K) from Underweight to Equal-Weight and set a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:10 pm

GO

Morgan Stanley analyst Simeon Gutman has maintained an 'Underweight' rating on Grocery Outlet Holding (NASDAQ:GO) and lowered the price target from $27 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:10 pm

APO

FTNT

WYNN

On CNBC's 'Halftime Report Final Trades', Stephanie Link of Hightower recommended Fortinet, Inc. (FTNT), Joseph Terranova of Virtus Investment Partners picked Apollo Global Management, Inc. (APO), and Jim Lebenthal of Cerity Partners named Wynn Resorts, Limited (WYNN) ahead of its quarterly earnings. Fortinet recently reported mixed quarterly results, while Apollo recently acquired a majority stake in Modern Aviation. Wynn Resorts is expected to post quarterly earnings of 75 cents per share on revenue of $1.59 billion.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 2:10 pm

GMAB

Morgan Stanley analyst Matthew Harrison maintains an Underweight rating on Genmab (NASDAQ:GMAB) and lowers the price target from $33 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:08 pm

FLT

Morgan Stanley analyst James Faucette has maintained an Equal-Weight rating on Fleetcor Technologies (NYSE:FLT) and lowered the price target from $244 to $240.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:06 pm

EWCZ

Morgan Stanley analyst Simeon Gutman has maintained an Equal-Weight rating on European Wax Center (NASDAQ:EWCZ) but lowered the price target from $18 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:05 pm

CTKB

Morgan Stanley analyst Tejas Savant has maintained an Equal-Weight rating on Cytek Biosciences (NASDAQ:CTKB) but lowered the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:02 pm

PH

Over the past 3 months, 4 analysts have published their opinion on Parker Hannifin (NYSE:PH) stock, all of them being bullish. The company has an average price target of $480.25, which has increased by 7.08% from the previous average price target of $448.50.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 2:00 pm

CYTK

Over the past 3 months, 9 analysts have published their opinion on Cytokinetics (NASDAQ:CYTK) stock, with an average price target of $60.56, implying an upside from the current price of $35.5. The current average has increased by 12.15% from the previous average price target of $54.00. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 2:00 pm

AVDX

In the last quarter, AvidXchange Holdings (NASDAQ:AVDX) received three somewhat bullish ratings and one indifferent rating from analysts. The average 12-month price target for the company is $11.0, a decrease of 26.67% from the previous average of $15.00.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 2:00 pm